Exela Technologies, Inc. ("Exela"), formed through the strategic combination of SourceHOV and Novitex is a location-agnostic global business process automation ("BPA") leader across numerous industries, combining industry-specific and multi-industry enterprise software and solutions with decades of experience. Our BPA suite of solutions are deployed in banking, healthcare, insurance and other industries to support mission critical environments. Exela is a leader in work flow automation, attended and un-attended cognitive automation, digital mail rooms, print communications, and payment processing with deployments across the globe. Exela partners with customers to improve user experience and quality through operational efficiency. Exela serves over 4,000 customers worldwide, through a secure, cloud-enabled global delivery model.
Exela became a public company on July 13, 2017.
Exela’s common stock is traded on the Nasdaq exchange under the ticker symbol “XELA.” Additionally, Exela has a Series B Preferred Stock that trades under “XELAP.”
Exela’s headquarter are located at 2701 E. Grauwyler Road Irving TX, USA
Exela was formed in 2017 and is incorporated in Delaware.
Exela currently does not have a direct stock purchase plan.
Exela common stock can be purchased on the open market through any registered broker.
Exela’s common stock currently does not pay a dividend. Exela issued Series B Preferred Stock with dividends payable quarterly on XELAP when, as and if declared by the Board of Directors.
All questions regarding ownership of Exela stock should be addressed to the appropriate transfer agent:
Continental Stock Transfer & Trust
1 State Street Plaza, 30th Floor
New York, New York 10004-1561
Tel: (212) 509 4000
The Exela fiscal year will run on a calendar year with quarters ending on March 31, June 30, September 30 and December 31.
Exela’s independent accountants are KPMG.
Please view a full list of Exela’s Board of Directors.
Exela has approximately 17,500 employees
Please fill the email alerts form to receive information about the company.
Please see our IR Contacts page for contact information.